Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arickx

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Orphanet Journal of Rare Diseases|December 25, 2013
Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countriesThomas Morel, Francis Arickx, Gustaf Befrits, et al.
Social Science & Medicine (1982)|December 25, 2019
Multiple Criteria Decision Analysis for HTA across four EU Member States: Piloting the Advance Value FrameworkA Angelis, M Linch, G Montibeller, et al.
Orphanet Journal of Rare Diseases|November 7, 2018
The European challenges of funding orphan medicinal productsMárta Szegedi, Tamás Zelei, Francis Arickx, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 23, 2023
Introducing a core dataset for real-world data in multiple sclerosis registries and cohorts: Recommendations from a global task forceTina Parciak, Lotte Geys, Anne Helme, et al.
Health Systems in Transition|December 9, 2016
Pharmaceutical regulation in 15 European countries reviewDimitra Panteli, Francis Arickx, Irina Cleemput, et al.
Frontiers in Pharmacology|October 14, 2016
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive PathwaysMichael Ermisch, Anna Bucsics, Patricia Vella Bonanno, et al.
Frontiers in Pharmacology|September 8, 2017
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential ImplementationPatricia Vella Bonanno, Michael Ermisch, Brian Godman, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Orphanet Journal of Rare Diseases|December 25, 2013
Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countriesThomas Morel, Francis Arickx, Gustaf Befrits, et al.
Social Science & Medicine (1982)|December 25, 2019
Multiple Criteria Decision Analysis for HTA across four EU Member States: Piloting the Advance Value FrameworkA Angelis, M Linch, G Montibeller, et al.
Orphanet Journal of Rare Diseases|November 7, 2018
The European challenges of funding orphan medicinal productsMárta Szegedi, Tamás Zelei, Francis Arickx, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 23, 2023
Introducing a core dataset for real-world data in multiple sclerosis registries and cohorts: Recommendations from a global task forceTina Parciak, Lotte Geys, Anne Helme, et al.
Health Systems in Transition|December 9, 2016
Pharmaceutical regulation in 15 European countries reviewDimitra Panteli, Francis Arickx, Irina Cleemput, et al.
Frontiers in Pharmacology|October 14, 2016
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive PathwaysMichael Ermisch, Anna Bucsics, Patricia Vella Bonanno, et al.
Frontiers in Pharmacology|September 8, 2017
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential ImplementationPatricia Vella Bonanno, Michael Ermisch, Brian Godman, et al.
Pageof 2